| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.054 | 0.2 |